MIC Capital Management (UK)’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $769K | Hold |
87,028
| – | – | 0.15% | 13 |
|
|
2025
Q1 | $936K | Hold |
87,028
| – | – | 0.19% | 14 |
|
|
2024
Q4 | $1.11M | Hold |
87,028
| – | – | 0.16% | 14 |
|
|
2024
Q3 | $2.4M | Hold |
87,028
| – | – | 0.33% | 14 |
|
|
2024
Q2 | $2.52M | Hold |
87,028
| – | – | 0.55% | 11 |
|
|
2024
Q1 | $3.88M | Hold |
87,028
| – | – | 0.74% | 14 |
|
|
2023
Q4 | $3.38M | Hold |
87,028
| – | – | 0.66% | 15 |
|
|
2023
Q3 | $2.56M | Sell |
87,028
-66,000
| -43% | -$1.94M | 0.58% | 15 |
|
|
2023
Q2 | $9.73M | Hold |
153,028
| – | – | 1.98% | 13 |
|
|
2023
Q1 | $7.22M | Hold |
153,028
| – | – | 1.38% | 15 |
|
|
2022
Q4 | $10.6M | Hold |
153,028
| – | – | 2.1% | 12 |
|
|
2022
Q3 | $22.4M | Hold |
153,028
| – | – | 4.04% | 7 |
|
|
2022
Q2 | $20M | Buy |
153,028
+87,028
| +132% | +$11.3M | 3.9% | 7 |
|
|
2022
Q1 | $6.67M | Hold |
66,000
| – | – | 1.3% | 17 |
|
|
2021
Q4 | $10.2M | Buy |
+66,000
| New | +$10.2M | 1.95% | 15 |
|